Searchable abstracts of presentations at key conferences in endocrinology

ea0020p391 | Diabetes and Cardiovascular | ECE2009

Visfatin seems not to be related in insulin resistance

Taslipinar Abdullah , Taslipinar Mine Y , Azal Omer , Kebapcilar Levent , Sahin Mustafa , Uckaya Gokhan , Sonmez Y Alper , Kucukerdonmez Ozge , Kutlu Mustafa

Visfatin is a newly discovered adipocyte hormone. Recent studies showed a possible relationship between diabetes mellitus and visfatin level. But the effect of visfatin on the insulin resistance was not well understood. The aim of the present study was to explore the relation of visfatin with insulin resistance in patients with prediabetes and diabetes.We included a total of 128 persons in the study and of these 128 persons, 36 were diabetic, 69 were pre...

ea0020p369 | Diabetes and Cardiovascular | ECE2009

Epicardial adipose tissue thickness and serum visfatin levels in patients with new diagnosed prediabetes and type 2 diabetes mellitus

Taslipinar Abdullah , Taslipinar Mine Y , Azal Omer , Sahin Mustafa , Kebapcilar Levent , Ozdemir Levent , Savashan Cagatay , Uckaya Gokhan , Koz Cem , Yaman Halil , Acikel Cengizhan , Kutlu Mustafa

The relation between obesity and diabetes mellitus is known for long periods and this relation is based on insulin resistance. Recent studies showed that epicardial adipose tissue thickness measured by echocardiography is the marker of the visceral adipose tissue and cardiovascular risk. Visfatin is a new described adipokine and it has been showed to have mRNA expression in epicardial adipose tissue. There is a conflict about the role of visfatin on obesity, insulin resistance...

ea0041ep380 | Clinical case reports - Thyroid/Others | ECE2016

Unusual presentation of primary hyperparathyroidism with coexisted thyroid carcinoma

Basaran Yalcin , Ince Semra , Alagoz Engin , Meric Coskun , Taslipinar Abdullah

Introduction: Brown tumor is a rare benign bone lesion with incidence ranging from 1.5% in primary hyperparathyroidism to 13% in secondary hyperparathyroidism. Common sites of involvement are pelvis, femur and ribs, but may appear in any bone. Since the incidence of thyroid disease is higher among patients with hyperparathyroidism than the general population, these lesions must be distinguished from metastases from thyroid carcinoma.We present a patient ...

ea0022p148 | Cardiovascular endocrinology and lipid metabolism | ECE2010

Searching for the metabolic syndrome criteria in young adults with hypogonadism

Sonmez Alper , Haymana Cem , Bolu Erol , Tapan Serkan , Barcin Cem , Aydogdu Aydogan , Taslipinar Abdullah , Kutlu Mustafa

Introduction: The evidence shows that the prevalence of metabolic syndrome is increased in patients with hypogonadism. However, much of the data regarding this association comes from the elderly patients with obesity, hypertension or type 2 diabetes. The total testosterone levels alter physiologically in these conditions and thus can falsify the association. We aimed to investigate the prevalence of the metabolic syndrome in young adults with hypogonadism who do not have any c...

ea0022p162 | Cardiovascular endocrinology and lipid metabolism | ECE2010

The effect of testesterone replacement therapy on HDL subfraction levels in hypogonadotropic hypogonadism

Taslipinar Abdullah , Sonmez Y Alper , Bolu Erol , Tapan Serkan , Uckaya Gokhan , Aydogdu Aydogan , Kutlu Mustafa

The high-density lipoprotein (HDL) levels are decreased in paitents with hypogonadotropic hypogonadism (HH). Although testosteron regulates lipoprotein metabolism, the effect of testosterone replacement therapy on HDL metabolism is not clearly shown in HH. The aim of this study is to determine the effects of testesterone replacement on HDL subfractions in young patients with HH. Forty-three cases with HH (mean age 21±2.45 years) were enrolled. Fifty-one healthy volunteer ...

ea0022p320 | Diabetes | ECE2010

Calcaneal spur incidence is increased in patients with type 2 diabetes mellitus

Aydogdu Aydogan , Akbulut Halil , Uckaya Gokhan , Taslipinar Abdullah , Sonmez Y Alper , Aydogan Umit , Kutlu Mustafa

Obesity is a risk factor for calcaneal spur (CS) formation which is supposed to originate from chronic plantar fasciitis. But histological findings support the thesis that ‘plantar fasciitis’ is a degenerative fasciosis without inflammation. Diabetes mellitus may contribute to the risk of CS by decreased ability of tissue repair and increased reactive ossification. Thus, we aimed to determine CS incidence in asymptomatic obese subjects with and without type 2 diabete...

ea0041ep542 | Diabetes therapy | ECE2016

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

Sonmez Alper , Dinc Mustafa , Taslipinar Abdullah , Aydogdu Aydogan , Meric Coskun , Basaran Yalcin , Haymana Cem , Demir Orhan , Azal Omer

Introduction: Intensive insulin treatment in obese patients with type 2 diabetes (T2DM) is often difficult. Insulin dosages are much higher, which further increase weight gain and the risk of hypoglycemia. Glucagon like peptide 1 receptor agonists (GLP-1RAs) are the promising treatment modalities causing weight loss and reducing the risk of hypoglycemia. There is no published data about the effect of adding on GLP1RAs to obese T2DM patients with un-controlled glucose levels un...

ea0022p697 | Obesity | ECE2010

Waist circumference does not reflect body fat distribution and insulin resistance in young male patients with idiopathic hypogonadotrophic hypogonadism

Aydogdu Aydogan , Kucukerdonmez Ozge , Uckaya Gokhan , Taslipinar Abdullah , Bolu S Erol , Sonmez Y Alper , Aydogan Umit , Kutlu Mustafa

Hypogonadism is associated with increased body fat content and insulin resistance. Many associations including ADA, IDF and EASD declare that waist circumference is a reliable measure of visceral adiposity and may account for insulin resistance. Our observations in young male patients with idiopathic hypogonadotrophic hypogonadism (IHH) are opposite. Thus, we aimed to compare body fat content and anthropometric measurements between patients and age-matched eugonadal healthy co...

ea0020p240 | Bone/Calcium | ECE2009

The effect of short term human chorionic gonadotropin treatment on the improvement of bone mass in patients with hypogonadotropic hypogonadism

Bolu Erol , Sonmez Alper , Apikoglu Mehmet , Gurel Hasan , Emer Ozdes , Taslipinar Abdullah , Ozguven M Ali , Kutlu Mustafa

Background: Idiopatic hypogonadotropic hypogonadism is a congenital abnormality due to GnRH deficiency which is associated with severe osteoporosis. Testosterone replacement has been shown to improve the loss in the bone mass. The aim of the present retrospective analysis was to measure the effect of human chorionic gonadotropin treatment on the improvement of bone mineral density.Methods: A total number of 96 young male (mean age 21±3.7 years) pati...

ea0041ep716 | Male Reproduction | ECE2016

The investigation of oxidative stress-related parameters in congenital hypogonadism

Haymana Cem , Aydogdu Aydogan , Soykut Bugra , Erdem Onur , Ibrahimov Tural , Dinc Mustafa , Meric Coskun , Taslipinar Abdullah , Basaran Yalcin , Sonmez Alper , Azal Omer

Introduction: Patients with hypogonadism are at increased risk of cardiac and metabolic diseases. The pathogenesis of increased cardio-metabolic risk in hypogonadal patients is not clear. Oxidative stress plays an important role in the pathogenesis of cardio-metabolic diseases. The aim of this study was to search for any difference of the oxidative stress parameters between in patients with hypogonadism and healthy controls.Materials and Methods: Thirty ...